ProPhase Labs Stock Price, News & Analysis (NASDAQ:PRPH)

$2.27 0.00 (0.00 %)
(As of 12/11/2017 06:00 AM ET)
Previous Close$2.27
Today's Range$2.26 - $2.27
52-Week Range$1.78 - $2.45
Volume2,300 shs
Average Volume21,777 shs
Market Capitalization$28.21 million
P/E Ratio2.95
Dividend YieldN/A
Beta0.18

About ProPhase Labs (NASDAQ:PRPH)

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.

Receive PRPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Special Foods & Welbeing Products
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PRPH
CUSIPN/A
Phone215-345-0919

Debt

Debt-to-Equity RatioN/A
Current Ratio13.88%
Quick Ratio13.06%

Price-To-Earnings

Trailing P/E Ratio2.95
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$21.01 million
Price / Sales1.34
Cash FlowN/A
Price / CashN/A
Book Value$0.35 per share
Price / Book6.49

Profitability

Trailing EPS$2.28
Net Income$-2,860,000.00
Net Margins307.58%
Return on Equity40.36%
Return on Assets35.40%

Miscellaneous

Employees53
Outstanding Shares12,430,000

ProPhase Labs (NASDAQ:PRPH) Frequently Asked Questions

What is ProPhase Labs' stock symbol?

ProPhase Labs trades on the NASDAQ under the ticker symbol "PRPH."

How will ProPhase Labs' stock buyback program work?

ProPhase Labs declared that its board has approved a stock buyback plan on Saturday, November 11th 2017, which allows the company to repurchase 1,700,000 shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through a tender offer. Shares repurchase plans are usually an indication that the company's board believes its stock is undervalued.

How were ProPhase Labs' earnings last quarter?

ProPhase Labs, Inc. (NASDAQ:PRPH) posted its quarterly earnings data on Monday, November, 13th. The company reported ($0.05) earnings per share for the quarter. The company earned $3.04 million during the quarter. ProPhase Labs had a return on equity of 40.36% and a net margin of 307.58%. View ProPhase Labs' Earnings History.

Who are some of ProPhase Labs' key competitors?

Who are ProPhase Labs' key executives?

ProPhase Labs' management team includes the folowing people:

  • Ted William Karkus, Chairman of the Board, Chief Executive Officer (Age 57)
  • Monica Brady, Principal Financial Officer & Principal Accounting Officer (Age 40)
  • Jason M. Barr, Director (Age 37)
  • Mark A. Burnett, Independent Director (Age 57)
  • Louis Gleckel M.D., Independent Director (Age 61)
  • James T. McCubbin, Independent Director (Age 52)

Who owns ProPhase Labs stock?

ProPhase Labs' stock is owned by many different of institutional and retail investors. Top institutional shareholders include KARKUS TED WILLIAM (22.90%) and BML INVESTMENT PARTNERS, L.P. (5.05%). Company insiders that own ProPhase Labs stock include Braden Michael Leonard, Jason Michael Barr, Robert V Cuddihy Jr and Ted William Karkus. View Institutional Ownership Trends for ProPhase Labs.

How do I buy ProPhase Labs stock?

Shares of ProPhase Labs can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ProPhase Labs' stock price today?

One share of ProPhase Labs stock can currently be purchased for approximately $2.27.

How big of a company is ProPhase Labs?

ProPhase Labs has a market capitalization of $28.21 million and generates $21.01 million in revenue each year. The company earns $-2,860,000.00 in net income (profit) each year or $2.28 on an earnings per share basis. ProPhase Labs employs 53 workers across the globe.

How can I contact ProPhase Labs?

ProPhase Labs' mailing address is 621 NORTH SHADY RETREAT ROAD, DOYLESTOWN PA, 18901. The company can be reached via phone at 215-345-0919 or via email at [email protected]


MarketBeat Community Rating for ProPhase Labs (PRPH)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about ProPhase Labs and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ProPhase Labs (NASDAQ:PRPH) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

ProPhase Labs (NASDAQ:PRPH) Earnings History and Estimates Chart

Earnings by Quarter for ProPhase Labs (NASDAQ:PRPH)

ProPhase Labs (NASDAQ PRPH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017Q3 2017($0.05)$3.04 millionViewN/AView Earnings Details
8/11/2017Q2 2017($0.09)$1.91 millionViewN/AView Earnings Details
11/14/2016Q3 2016$0.01$4.40 million$5.20 millionViewN/AView Earnings Details
3/25/2015Q414($0.05)$9.00 millionViewN/AView Earnings Details
11/13/2014Q314($0.18)$5.95 million$5.13 millionViewN/AView Earnings Details
3/27/2014Q413$0.04$9.08 million$9.60 millionViewN/AView Earnings Details
11/14/2013Q3$0.08$5.42 million$5.95 millionViewN/AView Earnings Details
3/26/2013Q412$0.04$7.46 million$9.08 millionViewN/AView Earnings Details
11/14/2012Q312$0.07$5.10 million$5.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

ProPhase Labs (NASDAQ:PRPH) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ProPhase Labs (NASDAQ:PRPH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

ProPhase Labs (NASDAQ PRPH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 29.60%
Institutional Ownership Percentage: 8.76%
Insider Trades by Quarter for ProPhase Labs (NASDAQ:PRPH)
Insider Trades by Quarter for ProPhase Labs (NASDAQ:PRPH)

ProPhase Labs (NASDAQ PRPH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/29/2017Braden Michael LeonardMajor ShareholderSell1,695,305$2.30$3,899,201.50View SEC Filing  
9/29/2017Jason Michael BarrDirectorSell4,379$2.30$10,071.70View SEC Filing  
9/29/2017Robert V Cuddihy JrCFOSell358,621$2.30$824,828.30View SEC Filing  
9/29/2017Ted William KarkusCEOSell364,950$2.30$839,385.00View SEC Filing  
6/4/2015Ted William KarkusMajor ShareholderBuy200,000$1.30$260,000.00View SEC Filing  
5/19/2015Ted William KarkusCEOBuy210,000$1.35$283,500.00View SEC Filing  
11/7/2014Braden Michael LeonardMajor ShareholderBuy64,746$1.34$86,759.64View SEC Filing  
10/9/2014Braden Michael LeonardMajor ShareholderBuy284,885$1.30$370,350.50View SEC Filing  
10/8/2014Braden Michael LeonardMajor ShareholderBuy114,910$1.30$149,383.00View SEC Filing  
10/2/2014Braden Michael LeonardMajor ShareholderBuy16,900$1.40$23,660.00View SEC Filing  
9/24/2014Braden Michael LeonardMajor ShareholderBuy48,596$1.40$68,034.40View SEC Filing  
9/23/2014Braden Michael LeonardMajor ShareholderBuy16$1.38$22.08View SEC Filing  
9/22/2014Braden Michael LeonardMajor ShareholderBuy44,042$1.40$61,658.80View SEC Filing  
9/18/2014Braden Michael LeonardMajor ShareholderBuy12,500$1.41$17,625.00View SEC Filing  
9/15/2014Braden Michael LeonardMajor ShareholderBuy121,940$1.45$176,813.00View SEC Filing  
5/23/2013Mark Shawn FrankDirectorBuy20,000$1.65$33,000.00View SEC Filing  
5/9/2013Mark S LeventhalDirectorBuy10,000$1.60$16,000.00View SEC Filing  
11/29/2012Mark S LeventhalDirectorBuy150,000$1.54$231,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

ProPhase Labs (NASDAQ PRPH) News Headlines

Source:
DateHeadline
Can ProPhase Labs Inc (PRPH) Continue To Outperform Its Industry?Can ProPhase Labs Inc (PRPH) Continue To Outperform Its Industry?
finance.yahoo.com - December 1 at 5:27 PM
ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017
finance.yahoo.com - November 24 at 9:03 AM
ProPhase buying back stock for a second time after Cold-Eeze saleProPhase buying back stock for a second time after Cold-Eeze sale
www.bizjournals.com - November 23 at 7:48 AM
ProPhase Labs, Inc. (PRPH) Announces  Earnings ResultsProPhase Labs, Inc. (PRPH) Announces Earnings Results
www.americanbankingnews.com - November 14 at 10:22 AM
ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017
finance.yahoo.com - November 14 at 7:00 AM
Prophase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common StockProphase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common Stock
finance.yahoo.com - November 12 at 11:53 AM
ProPhase Labs (PRPH) to Buyback 1,700,000 Outstanding SharesProPhase Labs (PRPH) to Buyback 1,700,000 Outstanding Shares
www.americanbankingnews.com - November 11 at 11:37 AM
ProPhase Labs, Inc. (PRPH) Downgraded by ValuEngine to "Sell"ProPhase Labs, Inc. (PRPH) Downgraded by ValuEngine to "Sell"
www.americanbankingnews.com - October 8 at 3:32 PM
Is ProPhase Labs Inc (PRPH) A Buy At Its Current Price?Is ProPhase Labs Inc (PRPH) A Buy At Its Current Price?
finance.yahoo.com - October 5 at 5:29 PM
Braden Michael Leonard Sells 1,695,305 Shares of ProPhase Labs, Inc. (PRPH) StockBraden Michael Leonard Sells 1,695,305 Shares of ProPhase Labs, Inc. (PRPH) Stock
www.americanbankingnews.com - October 2 at 4:34 PM
Robert V. Cuddihy, Jr. Sells 358,621 Shares of ProPhase Labs, Inc. (PRPH) StockRobert V. Cuddihy, Jr. Sells 358,621 Shares of ProPhase Labs, Inc. (PRPH) Stock
www.americanbankingnews.com - October 2 at 1:30 PM
ProPhase Labs, Inc. (PRPH) Director Jason Michael Barr Sells 4,379 SharesProPhase Labs, Inc. (PRPH) Director Jason Michael Barr Sells 4,379 Shares
www.americanbankingnews.com - October 2 at 1:30 PM
ProPhase Labs, Inc. (PRPH) CEO Ted William Karkus Sells 364,950 SharesProPhase Labs, Inc. (PRPH) CEO Ted William Karkus Sells 364,950 Shares
www.americanbankingnews.com - October 2 at 1:30 PM
ProPhase Labs, Inc. Announces Final Results of Its Tender OfferProPhase Labs, Inc. Announces Final Results of Its Tender Offer
www.streetinsider.com - October 1 at 6:23 PM
ProPhase Labs, Inc. Announces Final Results of Its Tender Offer - GlobeNewswire (press release)ProPhase Labs, Inc. Announces Final Results of Its Tender Offer - GlobeNewswire (press release)
globenewswire.com - September 29 at 12:12 PM
ProPhase Labs, Inc. Announces Preliminary Results of Its Tender OfferProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer
finance.yahoo.com - September 26 at 7:07 PM
ProPhase Labs (PRPH) Commences Tender Offer to Repurchase Up to 4M Shares of its Common Stock at Price of $2.30/ShareProPhase Labs (PRPH) Commences Tender Offer to Repurchase Up to 4M Shares of its Common Stock at Price of $2.30/Share
www.streetinsider.com - August 26 at 8:31 AM
ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 4.0 Million Shares of Its Common Stock at Price of $2.30 Per ShareProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 4.0 Million Shares of Its Common Stock at Price of $2.30 Per Share
finance.yahoo.com - August 26 at 8:30 AM
ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017ProPhase Labs, Inc. :PRPH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017
finance.yahoo.com - August 17 at 3:20 PM
Share Buyback Plan Approved by ProPhase Labs (PRPH) Board of Directors Share Buyback Plan Approved by ProPhase Labs (PRPH) Board of Directors
www.americanbankingnews.com - August 16 at 11:32 AM
ProPhase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 4,000,000 Shares of Its Common StockProPhase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 4,000,000 Shares of Its Common Stock
finance.yahoo.com - August 16 at 6:58 AM
ProPhase Labs, Inc. (PRPH) Releases Quarterly  Earnings ResultsProPhase Labs, Inc. (PRPH) Releases Quarterly Earnings Results
www.americanbankingnews.com - August 12 at 10:40 AM
ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2017ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2017
finance.yahoo.com - August 12 at 7:02 AM
ProPhase Labs (PRPH) Announces Buyback of 1.06M SharesProPhase Labs (PRPH) Announces Buyback of 1.06M Shares
www.streetinsider.com - June 15 at 4:52 AM
From Cold-Eeze to medical marijuana: Bucks County health care company makes hard turnFrom Cold-Eeze to medical marijuana: Bucks County health care company makes hard turn
www.bizjournals.com - April 7 at 12:02 PM
PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material DefinitPROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit
biz.yahoo.com - March 29 at 8:07 PM
PROPHASE LABS, INC. Files SEC form 10-K, Annual ReportPROPHASE LABS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - February 24 at 8:33 PM
ProPhase Labs (PRPH) to Sell Cold-EEZE for $50MProPhase Labs (PRPH) to Sell Cold-EEZE for $50M
www.streetinsider.com - January 10 at 1:01 AM
ProPhase Labs, Inc. Announces Agreement to Sell Cold-EEZE(R) BrandProPhase Labs, Inc. Announces Agreement to Sell Cold-EEZE(R) Brand
us.rd.yahoo.com - January 9 at 8:00 PM
7:31 am ProPhase to sell its Cold-EEZE cold remedy brand to Mylan (<a href="/q?s=myl" name="myl">MYL</a>) for $50 mln before taking into account taxes, transaction costs and related deal expenses, restructuring costs and post-closing escrow7:31 am ProPhase to sell its Cold-EEZE cold remedy brand to Mylan (MYL) for $50 mln before taking into account taxes, transaction costs and related deal expenses, restructuring costs and post-closing escrow
us.rd.yahoo.com - January 9 at 8:00 PM
ProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PMProPhase Labs Schedules an Investor Conference Call for Tuesday, January 10th at 4:30 PM
us.rd.yahoo.com - January 9 at 8:00 PM
PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights oPROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights o
biz.yahoo.com - January 9 at 8:00 PM
ProPhase Labs (PRPH) Reports Positive Verdict in Ongoing Phosphagenics ArbitrationProPhase Labs (PRPH) Reports Positive Verdict in Ongoing Phosphagenics Arbitration
www.streetinsider.com - November 17 at 6:40 PM
PROPHASE LABS INCPROPHASE LABS INC
www.finanznachrichten.de - August 10 at 10:02 AM
Q2 2016 ProPhase Labs Inc Earnings Release - After Market CloseQ2 2016 ProPhase Labs Inc Earnings Release - After Market Close
biz.yahoo.com - August 9 at 10:08 AM
ProPhase Labs: One Hit Wonder Or About To Explode?ProPhase Labs: One Hit Wonder Or About To Explode?
seekingalpha.com - June 22 at 6:53 PM
PROPHASE LABS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersPROPHASE LABS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - May 26 at 6:08 AM
PROPHASE LABS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsPROPHASE LABS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - January 15 at 6:05 AM
PROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial ObPROPHASE LABS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
biz.yahoo.com - December 16 at 4:32 PM
PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial StatemPROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statem
biz.yahoo.com - November 13 at 1:01 PM
PROPHASE LABS, INC. Files SEC form 10-Q, Quarterly ReportPROPHASE LABS, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 13 at 12:08 PM
PROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibPROPHASE LABS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
biz.yahoo.com - August 13 at 6:05 AM

SEC Filings

ProPhase Labs (NASDAQ:PRPH) SEC Filings

DateFilerForm TypeView

Social Media

Financials

ProPhase Labs (NASDAQ:PRPH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

ProPhase Labs (NASDAQ PRPH) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.